For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Meso momentum - April deadline for co-design of organisations to replace PHOs
+Bulletins
Meso momentum - April deadline for co-design of organisations to replace PHOs
Monday 4 March 2024, 03:00 PM

A vision for better health outcomes at population and individual levels has driven our mahi [Image: Paul Skorupskas on Unsplash]
Bryan Betty prescribes a transformative health system, focusing on transparency and accountability with whānau front and centre
There are big decisions to make; this isn’t about tweaking around the edges of the current status quo
General Practice NZ’s vision is to create a
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.